Page 1

Xxspray PHARMA INTERIM REPORT THIRD QUARTER 2021 Xspray Pharma is a pharmaceutical company that focuses on cost - efficient development of improved and generic versions of orphan drugs with high value , primarily protein kinase inhibitors ( PKIS ) . They are formulated as hybrid nanoparticles ( " HyNap " ) and are amorphous , patentable , and stable versions of crystalline original substances .